Skip to main content
. 2019 Jun 21;21(7):975–983. doi: 10.1111/jch.13603

Table 1.

Demographic, clinical, and target organ damage characteristics of the whole population at baseline and follow‐up

Characteristic

Mean (standard deviation)/number (%)

N = 422

Male sex (%) 245 (58%)
Age (y) 53.2 (13.0)
Systolic BP (mm Hg) 141.7 (17.7)
Δ Systolic BP (mm Hg) ‐9.2 (19.3)
Diastolic BP (mm Hg) 86.8 (10.8)
Δ Diastolic BP (mm Hg) ‐ 7.9 (12.2)
Heart Rate (bpm) 66.1 (11.1)
BMI (Kg/m2) 26.9 (4.1)
Smoking (%) 62 (15%)
Diabetes (%) 28 (7%)
Glucose (mg/dL) 88.1 (19.6)
Tryglicerides (mg/dL) 122.7 (73.7)
Total cholesterol (mg/dL) 196.6 (33.9)
HDL cholesterol (mg/dL) 53.1 (13.6)
LDL‐cholesterol (mg/dL) 118.9 (31.4)
Uric Acid (mg/dL) 5.2 (1.4)
Creatinine (mg/dL) 0.9 (0.2)
Glomerular Filtration Rate <60 mL/min (%) 19 (4.5%)
Pulse wave velocity (m/s) 8.5 (1.9)
Pulse wave velocity >10 m/s (%) 71 (17%)
Δ Pulse wave velocity (m/s) 0.6 (1.9)

Data are shown as means (standard deviation) or number(percentage). ΔPWV, ΔSBP, and ΔDBP represented the difference between the measurement at follow‐up and at baseline. Median follow‐up time was 3.85 y.

Abbreviations: BP, blood pressure; BMI, body mass index; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein.